PBGD Antibody (B-6): sc-166788

PBGD Antibody (B-6) is a mouse monoclonal IgG1 antibody that detects porphobilinogen deaminase (PBGD) in human samples through various applications including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), and enzyme-linked immunosorbent assay (ELISA). PBGD plays a crucial role in the heme synthesis pathway, catalyzing the conversion of porphobilinogen into hydroxymethylbilane, which is a key intermediate in the production of heme, an essential component of hemoglobin and various enzymes. Proper functioning of PBGD is vital, as deficiencies can lead to acute intermittent porphyria (AIP), a serious inherited disorder characterized by neurological dysfunctions, abdominal pain, and elevated levels of porphobilinogen and aminolevulinic acid in the urine. Understanding PBGD structure is important because multiple domains facilitate enzymatic activity and interactions with other proteins in the heme biosynthesis pathway. Integrity of these structural features is essential for maintaining normal metabolic processes, and any alterations can significantly impact heme production and lead to pathological conditions. Anti-PBGD antibody (B-6) is an invaluable tool for researchers studying PBGD implications in health and disease, providing insights into metabolic disorders and potential therapeutic targets.

The preferred PBGD antibody is PBGD Antibody (E-9): sc-166743.